(Total Views: 466)
Posted On: 04/02/2019 10:05:41 AM
Post# of 55
$SGMO News Article - Sangamo Provides Clinical Development Update Including Early Phase 1/2 Beta Thalassemia Gene-edited Cell Therapy Data https://marketwirenews.com/news-releases/sang...30304.html
(0)
(0)
My Twitter: WhyteStocks
